The prevalence and pathogenicity of propionibacterium acnes keratitis

Cornea

Volumn 28, Issue 1, 2009, Pages 36-39

  Ovodenko, Boris ^a   Seedor, John A ^a   Ritterband, David C ^a   Shah, Mahendra ^a   Yang, Renee ^a   Koplin, Richard S ^a  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

Author keywords

Corneal ulcer; Keratitis; Pathogenicity; Prevalence; Propionibacterium acnes

Indexed keywords

GATIFLOXACIN; MOXIFLOXACIN; STEROID; TOBRAMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTERIOR EYE CHAMBER; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM CULTURE; CHILD; CONTACT LENS; CONTROLLED STUDY; CORNEA STROMA; CORNEA ULCER; EYE SURGERY; FEMALE; HUMAN; HUMAN TISSUE; INFANT; KERATITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATHOGENICITY; PENETRATING KERATOPLASTY; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; RISK FACTOR; SCHOOL CHILD; STEROID THERAPY; BACTERIAL EYE INFECTION; GRAM POSITIVE INFECTION; MEDICAL RECORD; MICROBIOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CONTACT LENSES; CORNEAL ULCER; EYE INFECTIONS, BACTERIAL; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFANT; KERATITIS; MALE; MEDICAL RECORDS; MIDDLE AGED; OPHTHALMOLOGIC SURGICAL PROCEDURES; PREVALENCE; PROPIONIBACTERIUM ACNES; YOUNG ADULT;

EID: 62149148202     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181839b1a     Document Type: Article

References (31)

1. Perkins RE, Kundsin RB, Pratt MV, et al. Bacteriology of normal and infected conjunctiva. J Clin Microbiol. 1975;1:147-149.
2. Ishige I, Eishi Y, Takemura T, et al. Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2005;1:33-42.
3. Zambrano W, Flynn HW, Pflugfelder SC, et al. Management options for Propionibacterium acnes endophthalmitis. Ophthalmology. 1989;96: 1100-1105.
4. Underdahl JP, Florakis GJ, Braunstein RE, et al. Propionibacterium acnes as a cause of visually significant corneal ulcers. Cornea. 2000;19:451-454.
5. Geria RC, Wainsztein RD, Brunzini M, et al. Infectious keratitis in the corneal graft: treatment with partial conjunctival flaps. Ophthalmic Surg Lasers Imaging. 2005;36:298-302.
6. Meisler DM, Palestine AG, Vastine DW, et al. Chronic Propionibacterium endophthalmitis after extracapsular cataract extraction and posterior chamber intraocular lens implantation. Am J Ophthalmol. 1986;102: 733-739.
7. Gutierrez-Diaz E, Montero-Rodriguez M, Mencia-Gutierrez E, et al. Propionibacterium acnes endophthalmitis in Ahmed glaucoma valve. Eur J Ophthalmol. 2001;11:383-385.
8. Zaidman GW.Propionibacterium acnes keratitis. Am J Ophthalmol. 1992; 113:596-597.
9. Morel C, Harrabi S, Chaumeil C, et al. Positive corneal findings of Propionibacterium acnes and keratitis. J Fr Ophtalmol. 1996;19:4-7.
10. Jakab E, Zbinden R, Gubler J, et al. Severe infections caused by Propionibacterium acnes: an underestimated pathogen in late postoperative infections. Yale J Biol Med. 1996;69:477-482.
11. Brüggemann H. Insights in the pathogenic potential of Propionibacterium acnes from its complete genome. Semin Cutan Med Surg. 2005;24:67-72.
12. Scott DG, Cunliffe WJ, Gowland G. Activation of complement - a mechanism for the inflammation in acne. Br J Dermatol. 1979;101:315-320.
13. Webster GF, Leyden JJ, Norman ME, et al. Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum. Infect Immun. 1978;22:523-529.
14. Webster GF, Leyden JJ, Nilsson UR. Complement activation in acne vulgaris: consumption of complement by comedones. Infect Immun. 1979;26:183-186.
15. Vowels BR, Yang S, Leyden JJ. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun. 1995;63:3158-3165.
16. Zachariae CO. Chemotactic cytokines and inflammation. Biological properties of the lymphocyte and monocyte chemotactic factors ELCF, MCAF and IL-8. Acta Derm Venereol Suppl (Stockh). 1993;181:1-37.
17. Hoeffler U, Ko HL, Pulverer G. Antimicrobial susceptibility of Propionibacterium acnes and related microbial species. Antimicrob Agents Chemother. 1976;10:387-394.
18. Hoeffler U. Enzymatic and hemolytic properties of Propionibacterium acnes and related bacteria. J Clin Microbiol. 1977;6:555-558.
19. Ingham E, Holland KT, Gowland G, et al. Purification and partial characterization of an acid phosphatase (EC 3.1.3.2) produced by Propionibacterium acnes. J Gen Microbiol. 1980;118:59-65.
20. Puhvel SM, Reisner RM. The production of hyaluronidase (hyaluronate lyase) by Corynebacterium acnes. J Invest Dermatol. 1972;58:66-70.
21. Suzuki T, Sano Y, Sasaki O, et al. Ocular surface inflammation induced by Propionibacterium acnes. Cornea. 2002;21:812-817.
22. Iversen OJ, Dalen AB, Svindland HB. Isolation of an acidic polysaccharide antigen from Propionibacterium acnes. Arch Dermatol Res. 1985;277:225-229.
23. Tomita S, Kato H, Fujimoto T, et al. Cytopathogenic protein in filtrates from cultures of Propionibacterium acnes isolated from patients with Kawasaki disease. Br Med J. 1987;295:1229-1232.
24. Kato H, Fujimoto T, Inoue O, et al. Variant strain of Propionibacterium acnes: a clue to the aetiology of Kawasaki disease. Lancet. 1983;2:1383- 1388.
25. Koneman E, Allen S, eds. Koneman's Color Atlas and Textbook of Diagnostic Microbiology. Philadelphia, PA: Lippincott Williams and Wilkins; 2006.
26. Wang WL, Everett ED, Johnson M, et al. Susceptibility of Propionibacterium acnes to seventeen antibiotics. Antimicrob Agents Chemother. 1977;11:171-173.
27. Denys GA, Jerris RC, Swenson JM, et al. Susceptibility of Propionibacterium acnes clinical isolates to 22 antimicrobial agents. Antimicrob Agents Chemother. 1983;23:335-337.
28. Ednie LM, Jacobs MR, Appelbaum PC. Activities of gatifloxacin compared to those of 7 other agents against anaerobic organisms. Antimicrob Agents Chemother. 1998;42:2459-2462.
29. Hariprasad SM, Mieler WF, Holz ER. Vitreous and aqueous penetration of orally administered gatifloxacin in humans. Arch Ophthalmol. 2003;121: 345-350.
30. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 4th ed. Villanova, PA: National Committee for Clinical Laboratory Standards; 2000.
31. Hall GS, Pratt-Rippin K, Meisler DM, et al. Minimum bactericidal concentrations of Propionibacterium acnes isolates from cases of chronic endophthalmitis. Diagn Microbiol Infect Dis. 1995;21:187-190.